Cyclosporine in Treating Patients With Recurrent or Refractory Angioimmunoblastic T-Cell Lymphoma
Clinical trial NCT00070291 · TERMINATED
Trial details
- NCT number
- NCT00070291
- Sponsor
- Eastern Cooperative Oncology Group
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-01-24
- Primary completion
- 2009-03-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.